Clinical visits by patients suffering ocular surface eye conditions more than doubled during times when ambient particulate ...

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...

The study sheds light on how specific mutations may lead to the retinal disease retinitis pigmentosa. Importantly, these findings could also open the door to new diagnostic tests and treatments for a ...

Common ocular autoimmune diseases include thyroid eye disease, orbital inflammatory pseudotumor ... prevention, diagnosis, and treatment. This Research Topic aims to explore advancements in the ...

Hopkins researchers are further investigating 32-134D in wet AMD and diabetic eye disease, as well as other blinding diseases ...

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...

The US regulatory agency has pushed the PDUFA date by three months to 18 March 2025 to “allow for more time to review ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

On its website, the company says coping with amblyopia is "tough enough"—but getting treated for it doesn’t have to be.

These are known as disease-modifying treatments. One of these, lecanemab, has been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very ...

Constipation in Crohn’s disease may be caused by lifestyle and dietary factors, as well as medical conditions like strictures. Treatment may include eating more fiber, taking laxatives ...

Retinal detachment is a medical emergency that requires prompt treatment to avoid blindness and other complications. Retinal detachment can cause total loss of sight in the affected eye without ...